207 related articles for article (PubMed ID: 25638156)
1. RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel.
Guo J; Yang Y; Yang Y; Linghu E; Zhan Q; Brock MV; Herman JG; Zhang B; Guo M
Oncotarget; 2015 Feb; 6(6):4202-13. PubMed ID: 25638156
[TBL] [Abstract][Full Text] [Related]
2. Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancer.
Dong T; Zhang M; Dong Y; Herman JG; van Engeland M; Zhong G; Guo M
Discov Med; 2015 Nov; 20(111):261-71. PubMed ID: 26645898
[TBL] [Abstract][Full Text] [Related]
3. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
Fan C; Wang W; Jin J; Yu Z; Xin X
Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
[TBL] [Abstract][Full Text] [Related]
4. RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker.
Jin Y; Cao B; Zhang M; Zhan Q; Herman JG; Yu M; Guo M
Genes Cancer; 2015 May; 6(5-6):231-40. PubMed ID: 26124922
[TBL] [Abstract][Full Text] [Related]
5. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway.
Li X; Liang Q; Liu W; Zhang N; Xu L; Zhang X; Zhang J; Sung JJ; Yu J
Oncogene; 2016 May; 35(19):2453-64. PubMed ID: 26279301
[TBL] [Abstract][Full Text] [Related]
6. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
[TBL] [Abstract][Full Text] [Related]
7. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
[TBL] [Abstract][Full Text] [Related]
8. RASSF10 is epigenetically inactivated and induces apoptosis in lung cancer cell lines.
Wang Y; Ma T; Bi J; Song B; Zhou Y; Zhang C; Gao M
Biomed Pharmacother; 2014 Apr; 68(3):321-6. PubMed ID: 24433832
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signalling.
Yan W; Wu K; Herman JG; Brock MV; Zhou Y; Lu Y; Zhang Z; Yang Y; Guo M
J Cell Mol Med; 2014 Dec; 18(12):2499-511. PubMed ID: 24912879
[TBL] [Abstract][Full Text] [Related]
10. Methylation of
Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
[TBL] [Abstract][Full Text] [Related]
11. Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers.
Hu X; Sui X; Li L; Huang X; Rong R; Su X; Shi Q; Mo L; Shu X; Kuang Y; Tao Q; He C
J Pathol; 2013 Jan; 229(1):62-73. PubMed ID: 22926751
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
[TBL] [Abstract][Full Text] [Related]
13. Anticancer bioactive peptides suppress human colorectal tumor cell growth and induce apoptosis via modulating the PARP-p53-Mcl-1 signaling pathway.
Su LY; Shi YX; Yan MR; Xi Y; Su XL
Acta Pharmacol Sin; 2015 Dec; 36(12):1514-9. PubMed ID: 26592508
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer.
Yan W; Wu K; Herman JG; Brock MV; Fuks F; Yang L; Zhu H; Li Y; Yang Y; Guo M
Epigenetics; 2013 Dec; 8(12):1373-83. PubMed ID: 24149323
[TBL] [Abstract][Full Text] [Related]
15. FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53.
Xu M; Zhu J; Liu S; Wang C; Shi Q; Kuang Y; Fang X; Hu X
Carcinogenesis; 2020 Sep; 41(9):1253-1262. PubMed ID: 31784734
[TBL] [Abstract][Full Text] [Related]
16. 8-Acetonyldihydronitidine inhibits the proliferation of human colorectal cancer cells via activation of p53.
Zhou J; Li Z; Zhang J; Wang H; Yin S; Du J
Eur J Pharmacol; 2019 Jul; 854():256-264. PubMed ID: 30928633
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer.
Gil EY; Jo UH; Jeong H; Whang YM; Woo OH; Cho KR; Seo JH; Kim A; Lee ES; Koh I; Kim YH; Park KH
Int J Oncol; 2012 Aug; 41(2):611-20. PubMed ID: 22581300
[TBL] [Abstract][Full Text] [Related]
18. CP-31398 prevents the growth of p53-mutated colorectal cancer cells in vitro and in vivo.
He X; Kong X; Yan J; Yan J; Zhang Y; Wu Q; Chang Y; Shang H; Dou Q; Song Y; Liu F
Tumour Biol; 2015 Mar; 36(3):1437-44. PubMed ID: 25663456
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
[TBL] [Abstract][Full Text] [Related]
20. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
